Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

French center synthesizes new agents for bone disorders

June 20, 2012

Jenrin Discovery develops new agents targeting CB1 receptor

June 20, 2012

Novel agents for AIDS prepared at Pfizer

June 20, 2012

Novel products for tuberculosis designed at Sanofi

June 20, 2012

German group discloses new agents for dermatological disorders

June 20, 2012

Novartis reports novel CDK9 inhibitors

June 20, 2012

Scientists at Roche report novel tyrosine-protein kinase inhibitors

June 19, 2012

Sanofi divulges new chlamydia vaccines

June 19, 2012

Heptares Therapeutics patents new adenosine A2A receptor antagonists

June 19, 2012

New CDK9 inhibitors presented by Novartis

June 19, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...